POGGESI, ITALO
 Distribuzione geografica
Continente #
EU - Europa 961
NA - Nord America 814
AS - Asia 586
SA - Sud America 64
AF - Africa 32
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.466
Nazione #
US - Stati Uniti d'America 788
NL - Olanda 475
CN - Cina 280
IE - Irlanda 142
SG - Singapore 137
RU - Federazione Russa 79
HK - Hong Kong 59
DE - Germania 50
IT - Italia 47
BR - Brasile 45
VN - Vietnam 43
FI - Finlandia 41
UA - Ucraina 35
ZA - Sudafrica 23
GB - Regno Unito 21
FR - Francia 19
SE - Svezia 15
IN - India 14
CA - Canada 13
PL - Polonia 12
MX - Messico 9
AR - Argentina 8
BD - Bangladesh 8
AU - Australia 7
IQ - Iraq 5
KR - Corea 5
LT - Lituania 5
CO - Colombia 4
ES - Italia 4
JP - Giappone 4
TR - Turchia 4
AT - Austria 3
BE - Belgio 3
EC - Ecuador 3
ET - Etiopia 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
ID - Indonesia 1
JM - Giamaica 1
LK - Sri Lanka 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
SN - Senegal 1
TW - Taiwan 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 2.466
Città #
Dublin 142
Chandler 100
Singapore 96
San Jose 76
Beijing 67
Hong Kong 58
Ashburn 50
Dallas 49
Jacksonville 49
Nanjing 45
Boardman 32
Los Angeles 30
Helsinki 22
Johannesburg 21
Princeton 20
Wilmington 19
Hebei 17
Lawrence 17
Nanchang 17
Shanghai 17
Medford 16
Dearborn 15
Jiaxing 15
Lauterbourg 15
Changsha 14
Ho Chi Minh City 14
Milan 13
Shenyang 13
Ann Arbor 12
Moscow 12
Buffalo 9
Hanoi 9
Munich 9
New York 9
Pavia 8
Tianjin 8
Warsaw 8
Hangzhou 7
Orem 7
Redondo Beach 7
Toronto 7
Chicago 6
Seattle 6
São Paulo 6
Atlanta 5
Houston 5
Irvington 5
Mexico City 5
San Francisco 5
Santa Clara 5
Cagliari 4
Council Bluffs 4
Frankfurt am Main 4
Piscataway 4
Tokyo 4
Woodbridge 4
Bangkok 3
Belo Horizonte 3
Brooklyn 3
Brussels 3
Hải Dương 3
Krakow 3
Montreal 3
Mumbai 3
Nuremberg 3
Saint Petersburg 3
Sydney 3
The Dalles 3
Zhengzhou 3
Addis Ababa 2
Augusta 2
Bishkek 2
Boston 2
Brasília 2
Bratislava 2
Changchun 2
Charlotte 2
Chennai 2
Coimbra 2
Concord 2
Da Nang 2
Denver 2
Dhaka 2
Düsseldorf 2
Garching 2
Hackney 2
Kuching 2
Kuwait City 2
London 2
Manhumirim 2
Nairobi 2
New Delhi 2
Norwalk 2
Nova Iguaçu 2
Perth 2
Poplar 2
Quito 2
Quận Hai 2
Recife 2
Santiago 2
Totale 1.344
Nome #
Steady-state equivalence of drug- and biomarker driven models in tumor growth experiments 590
Tumor-growth inhibition in preclinical animal studies: steady-state analysis of biomarker-driven models 175
Biomarker-driven models of tumor growth inhibition in preclinical animal studies 151
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression 128
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies 118
Tumor growth modelling for drug development 115
Use of Physiology-Based Elements to Predict the Pharmacokineticsof New Drugs 115
Method to evaluate the systemic exposure in toxicological and pharmacological studies 106
Current mathematical models for cancer drug discovery 105
Predictive assessments of pharmacokinetic alterations in subjects with renal disease 102
Biomarker- versus drug-driven tumor growth inhibition models: an equivalence analysis 98
Mathematical modeling of efficacy and safety for anticancer drugs clinical development 96
Pharmacokinetic-Pharmacodynamic Modeling in Drug Development with Special Reference to Oncology 94
A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial Hypertension 89
Biomarker- versus drug-driven tumor growth inhibition models: an equivalence analysis 86
A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib 85
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial 84
Modeling approaches for reducing safety-related attrition in drug discovery and development: a review on myelotoxicity, immunotoxicity, cardiovascular toxicity, and liver toxicity 83
Prediction of the Effect of Renal Impairment on the Pharmacokinetics of New Drugs 80
Totale 2.500
Categoria #
all - tutte 8.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022562 1 1 4 0 1 2 0 18 1 0 16 518
2022/2023340 40 27 10 12 25 25 1 19 161 3 7 10
2023/2024129 32 20 0 12 8 17 9 15 2 4 6 4
2024/2025311 8 24 6 4 23 4 7 30 97 7 39 62
2025/2026772 61 45 74 85 121 34 130 31 86 80 15 10
Totale 2.500